Literature DB >> 10403279

T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles.

A P Cope1, S D Patel, F Hall, M Congia, H A Hubers, G F Verheijden, A M Boots, R Menon, M Trucco, A W Rijnders, G Sønderstrup.   

Abstract

OBJECTIVE: To analyze the CD4+ T cell responses to the human cartilage antigen glycoprotein-39 (HCgp-39) in the context of rheumatoid arthritis (RA)-associated (DRalphabeta1*0401) and nonassociated (DRalphabeta1*0402) HLA class II molecules.
METHODS: Large numbers of HCgp-39-specific T cell hybridomas were generated following immunization of HLA-DR4/human CD4 transgenic, murine major histocompatibility complex class II deficient mice with native HCgp-39. Fine epitope mapping of DRalphabeta1*0401-and DRalphabeta1*0402-restricted T cell hybridomas was performed using overlapping synthetic peptides. Antigen-specific cytokine production by lymph node T cells was evaluated after immunization with native antigen. Proliferative T cell responses of healthy human subjects were compared with the T cell responses of patients with active RA using HCgp-39 epitopes defined in HLA-DR4 transgenic mice.
RESULTS: CD4+ T cells from DRalphabeta1*0401 and DRalphabeta1*0402 transgenic mice identified completely different immunodominant peptide epitopes of HCgp-39, and this was not explained by known DR4-binding motifs or direct peptide-binding studies. DRalphabeta1*0401-restricted, antigen-specific T cells produced significantly more interferon-gamma and tumor necrosis factor a in response to HCgp-39 than did T cells from DRalphabeta1*0402 transgenic mice. Finally, HCgp-39 peptides defined in DRalphabeta1*0401 transgenic mice stimulated T cells from HLA-DR4 positive human subjects and RA patients, but not T cells from HLA-DR4 negative individuals.
CONCLUSION: T cell epitopes of HCgp-39 that were defined in HLA-DR4 transgenic mice stimulated T cells from human subjects carrying RA-associated HLA-DR4 alleles. HLA-DR4 molecules may influence the disease process in RA both by presentation of selected peptide epitopes and by promoting the production of proinflammatory cytokines in synovial joints.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403279     DOI: 10.1002/1529-0131(199907)42:7<1497::AID-ANR25>3.0.CO;2-#

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  22 in total

Review 1.  Antigen-specific T cells in rheumatoid arthritis.

Authors:  Sean R Bennett; Michael T Falta; Jerry Bill; Brian L Kotzin
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

2.  A triple altered collagen II peptide with consecutive substitutions of TCR contacting residues inhibits collagen-induced arthritis.

Authors:  Zhong-Qiang Yao; Ru Li; Zhan-Guo Li
Journal:  Ann Rheum Dis       Date:  2007-03       Impact factor: 19.103

Review 3.  Inhibition of IL-1, IL-6, and TNF-alpha in immune-mediated inflammatory diseases.

Authors:  Burkhard Möller; Peter M Villiger
Journal:  Springer Semin Immunopathol       Date:  2006-05-09

Review 4.  Transgenic models of autoimmune disease.

Authors:  R J Boyton; D M Altmann
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

5.  Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis.

Authors:  B L Kotzin; M T Falta; F Crawford; E F Rosloniec; J Bill; P Marrack; J Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 6.  Induction of immune tolerance in the treatment of rheumatoid arthritis.

Authors:  Salvatore Albani; Eva C Koffeman; Berent Prakken
Journal:  Nat Rev Rheumatol       Date:  2011-04-05       Impact factor: 20.543

7.  Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis.

Authors:  Jolanda H M van Bilsen; Henrike van Dongen; Leroy R Lard; Ellen I H van der Voort; Diënne G Elferink; Aleida M Bakker; André M M Miltenburg; Tom W J Huizinga; René R P de Vries; René E M Toes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

8.  T cell receptor zeta reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor alpha.

Authors:  Joanna M Clark; Alexander E Annenkov; Manvinder Panesar; Pia Isomäki; Yuti Chernajovsky; Andrew P Cope
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

Review 9.  Current concepts in the pathogenesis of early rheumatoid arthritis.

Authors:  Arthur G Pratt; John D Isaacs; Derek L Mattey
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-02       Impact factor: 4.098

10.  Dendritic cell mediated delivery of plasmid DNA encoding LAMP/HIV-1 Gag fusion immunogen enhances T cell epitope responses in HLA DR4 transgenic mice.

Authors:  Gregory G Simon; Yongli Hu; Asif M Khan; Jingshi Zhou; Jerome Salmon; Priya R Chikhlikar; Keun-Ok Jung; Ernesto T A Marques; J Thomas August
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.